Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-10 ,pp. : 586-591

Karger

Access to resources Recommend Favorite

Refining remission evaluation in MDS with isolated del(5q)

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 469-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complete Remission with a Combination of Lenalidomide, Cyclophosphamide and Prednisolone in a Patient with Incomplete POEMS Syndrome

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-08 ,pp. : 199-201

Karger

Access to resources Recommend Favorite

Long-Term Response in a Patient with del(5q) Myelodysplastic Syndrome Who Discontinued Lenalidomide and Obtained a Good Response and Tolerance to Rechallenge

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-04 ,pp. : 277-284

Karger

Access to resources Recommend Favorite

A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy

By  

Oncology Research and Treatment, Vol. 40, Iss. 1-2, 2017-01 ,pp. : 46-48

Karger

Access to resources Recommend Favorite